Mycetoma is a chronic infection that slowly destroys skin, muscle, and bone tissue. It primarily affects the foot, which is why it was historically called “Madura foot” after being first documented in Madurai, India in the mid-19th century. This infection occurs when bacteria or fungi from soil enter the body through minor skin wounds, especially in people who walk barefoot in tropical and subtropical regions.
Table of Contents
What causes mycetoma?
Mycetoma develops from traumatic inoculation of microorganisms into subcutaneous tissue, typically through thorn pricks or small cuts. The infection can be caused by two types of organisms:
Actinomycetoma is caused by bacteria, primarily from the actinomycetes group. Common causative bacteria include Nocardia species, Actinomadura madurae, and Streptomyces somaliensis. Eumycetoma is caused by fungi, most commonly Madurella mycetomatis and other filamentous fungi.
Over 70 different bacteria and fungi have been identified as potential causes of mycetoma. The specific organisms vary by geographic location. In India, actinomycetoma is more common in states like Tamil Nadu, Andhra Pradesh, and West Bengal, while fungal mycetoma predominates in Rajasthan.
Who is at risk?
The disease primarily affects young adults between 15 and 40 years of age, with men being affected three times more often than women. Manual workers such as farmers, laborers, and herders are most commonly affected because they frequently work barefoot in soil contaminated with these organisms.
Endemic areas, collectively known as the “Mycetoma Belt,” include countries in Africa, Asia, and Latin America. India reports significant numbers of cases, particularly from Rajasthan (33.3 cases per year), Tamil Nadu (16.8 cases per year), and West Bengal (13.2 cases per year).
How does mycetoma develop?
After the causative organism enters through a skin wound, the infection develops slowly over months to years. The process is usually painless initially, which often delays diagnosis and treatment. The infection progressively destroys body tissue beneath the skin, affecting muscles, tendons, fascia, and eventually bone.
The characteristic features develop gradually. Small, firm nodules appear first, which then enlarge and form suppurative lesions. Multiple sinus tracts develop that discharge pus containing distinctive granules or “grains.” These grains are actually colonies of the causative organisms and can be white, yellow, red, brown, or black depending on the specific pathogen involved.
Clinical presentation and symptoms
Mycetoma is characterized by a classic triad of symptoms:
Tumefaction: Painless subcutaneous swelling that gradually increases in size over time. The affected area becomes indurated due to dermal sclerosis.
Sinus formation: Multiple sinuses develop that connect to the skin surface. These sinuses discharge purulent or serosanguineous material.
Grain discharge: The discharge contains characteristic grains that help identify the causative organism. The color and size of grains provide diagnostic clues.
The foot is involved in approximately 70-80% of cases, though mycetoma can affect any body part. Actinomycetomas progress to bone invasion more rapidly than eumycetomas and may occur more frequently on the chest, abdomen, and head compared to fungal mycetoma.
Complications
Untreated mycetoma leads to severe complications. The infection extends into deep structures, causing destruction of muscles, tendons, and bones. Advanced cases show marked edema and deformity of the affected limb, forming a club-shaped mass with multiple interconnected sinuses.
Secondary bacterial infection, commonly with Staphylococcus aureus, can develop and cause increased pain, disability, and potentially fatal septicemia if left untreated. The progressive nature of the disease can result in muscle wasting, ankylosis, and loss of limb function, ultimately necessitating amputation in severe cases.
Diagnosis
Diagnosis requires both clinical evaluation and laboratory confirmation. Clinical diagnosis is based on the symptomatic triad and examination of discharged grains. Samples can be obtained through fine needle aspiration or surgical biopsy.
Microscopic examination of grains helps differentiate between bacterial and fungal causes. Culture of the organisms is essential for species identification, though this can be challenging and time-consuming. Molecular methods like PCR provide the most reliable identification but are expensive and not widely available in endemic areas.
Imaging techniques play a crucial role in assessing disease extent. Ultrasound is commonly used in endemic areas to distinguish mycetoma from other subcutaneous lesions. X-rays reveal bone involvement, showing characteristic findings like soft tissue swelling, bone sclerosis, and cavities. MRI and CT scans provide detailed assessment of tissue involvement and are valuable for surgical planning.
Treatment approaches
Treatment depends entirely on whether the infection is bacterial or fungal, making accurate identification crucial.
Actinomycetoma treatment
Bacterial mycetoma generally responds well to medical treatment with cure rates as high as 90%. The first-line treatment is co-trimoxazole (trimethoprim-sulfamethoxazole), either alone or combined with penicillin, dapsone, or an aminoglycoside. Treatment typically continues for several months, and surgery is rarely needed.
Eumycetoma treatment
Fungal mycetoma presents greater treatment challenges. Itraconazole is the standard antifungal agent, administered for 9-12 months or longer. However, cure rates are often low at 25-35%, and recurrence is common. Surgical excision is frequently combined with antifungal therapy to improve outcomes.
In cases where medical and surgical treatment fails, or when the disease is too advanced, amputation may be the only option to prevent further spread. Even after amputation, recurrence rates remain high, highlighting the difficulty in managing fungal mycetoma.
Prevention strategies
Prevention focuses on reducing exposure to causative organisms and preventing skin trauma. Wearing protective footwear is the most important preventive measure, as it protects against percutaneous injury from contaminated soil and thorns.
In endemic areas, health education should emphasize the importance of shoes and protective clothing for agricultural workers. Prompt cleaning and disinfection of wounds when they occur may help prevent infection. Early detection through community awareness programs can lead to treatment before severe complications develop.
Public health significance
The World Health Organization recognized mycetoma as a neglected tropical disease in 2016. Despite this recognition, accurate epidemiological data remain limited. The disease is not notifiable in most countries, making surveillance difficult.
Mycetoma causes significant morbidity and socioeconomic burden. Affected individuals often cannot work, leading to loss of income and poverty. The disfigurement and disability result in social stigma and mental health challenges. Treatment is lengthy, expensive, and often unavailable in rural endemic areas where it is most needed.
What do you think? How can healthcare systems in endemic regions improve early detection and treatment access for mycetoma? What role can community health workers play in preventing this debilitating disease through education about protective footwear?
Leave a Reply